Mostrar el registro sencillo del ítem
| dc.contributor.author | Nathan, Arjun | |
| dc.contributor.author | Gao, Chuanyu | |
| dc.contributor.author | Light, Alexander | |
| dc.contributor.author | Alexander, Cameron-E | |
| dc.contributor.author | Chan, Vinson | |
| dc.contributor.author | Gallagher, Kevin | |
| dc.contributor.author | Khadhouri, Sinan | |
| dc.contributor.author | Byrnes, Kevin-G | |
| dc.contributor.author | Ng, Michael | |
| dc.contributor.author | Walters, Michael | |
| dc.contributor.author | Hughes, Terry | |
| dc.contributor.author | Perry, Rita-J | |
| dc.contributor.author | Okoth, Kelvin | |
| dc.contributor.author | Magill, Laura | |
| dc.contributor.author | Pinkney, Thomas | |
| dc.contributor.author | Zhang, Yuhao | |
| dc.contributor.author | Blackmur, James | |
| dc.contributor.author | Etchill, Eric | |
| dc.contributor.author | Tang, Stanley | |
| dc.contributor.author | García-Escudero, Damián | |
| dc.contributor.author | McNeill, Alan | |
| dc.contributor.author | Narahari, Krishna | |
| dc.contributor.author | Stewart, Grant-D | |
| dc.contributor.author | Kasivisvanathan, Veeru | |
| dc.date.accessioned | 2025-11-18T09:33:55Z | |
| dc.date.available | 2025-11-18T09:33:55Z | |
| dc.date.issued | 2024 | |
| dc.identifier.citation | Nathan A, Gao C, Light A, Alexander C, Chan V, Gallagher K, et al. Early oncological outcomes of delayed radical prostatectomy: A prospective, international, follow-up analysis of the COVIDSurg-Cancer study. BJUI Compass. diciembre de 2024;5(12):1314-23. | |
| dc.identifier.issn | 2688-4526 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/20889 | |
| dc.description.abstract | OBJECTIVES: The objective of this study is to compare the early oncological outcomes of delayed (>90-days) versus scheduled (¿90-days) radical prostatectomy (RP). PATIENTS AND METHODS: Patients with prostate cancer due to undergo surgery between March 2020 and June 2020 who were enrolled in the COVIDSurg-Cancer international, observational study were prospectively followed up for 1 year. Time to surgery was defined as the difference between the operation date and the multi-disciplinary team decision to offer surgery. The primary outcome was the positive surgical margin (PSM) rate. Biochemical recurrence (BCR), upgradation and upstaging were secondary oncological outcomes. The Independent t-test and Mann Whitney U test were used to compare means between groups and regression models and were used to investigate factors associated with the primary outcome. RESULTS: Four hundred seventy-six (78.7%) patients underwent RP from 605 that were eligible. Three hundred seven (64.5%) patients underwent scheduled RP, and 169 (35.5%) underwent delayed RP. A small proportion of men (n =-35, 6.8%) did not undergo RP within the 1-year follow-up period. More men with high-risk disease (72.8%) underwent scheduled RP compared to men with intermediate-risk disease (60.2%) (p <-0.05). There was no statistically significant difference in the PSM rate between the two groups (p =-0.512). Delay in surgery was not associated with an increased PSM or BCR on univariable or multivariable analyses. There was statistically significantly greater upstaging (p <-0.05) in the delayed group but no difference in upgradation. CONCLUSION: High-risk men were prioritised for surgery during the COVID-19 pandemic. Our prospective data support previous retrospective, cancer-registry evidence suggesting no adverse oncological impact after delaying RP across all risk groups. Our study is limited by the short follow-up period, and therefore, longer term conclusions cannot be drawn. | |
| dc.language.iso | eng | |
| dc.publisher | John Wiley And Sons Inc | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Blepharospasm/drug therapy | |
| dc.subject.mesh | Botulinum Toxins/adverse effects | |
| dc.subject.mesh | Hemifacial Spasm/drug therapy | |
| dc.subject.mesh | Prospective Studies | |
| dc.subject.mesh | Dystonia/drug therapy | |
| dc.subject.mesh | Anterior Chamber | |
| dc.subject.mesh | Injections, Intraocular | |
| dc.subject.mesh | Botulinum Toxins, Type A/adverse effects | |
| dc.title | Early oncological outcomes of delayed radical prostatectomy: A prospective, international, follow-up analysis of the COVIDSurg-Cancer study | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 39744074 | |
| dc.relation.publisherversion | https://bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bco2.433 | |
| dc.identifier.doi | 10.1002/bco2.433 | |
| dc.journal.title | Bjui Compass |